New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2013
09:45 EDTABT, ABT, THOR, THOR, TFX, TFX, SYK, SYK, STJ, STJ, NUVA, NUVA, MDT, MDT, HTWR, HTWR, HSP, HSP, EW, EW, COV, COV, CFN, CFN, BDX, BDX, BSX, BSX, BCR, BCR, BAX, BAX, ZMH, ZMHBarclays' U.S. medical suppplies & devices analysts hold a conference call
U.S. Medical Supplies & Devices Research Team discuss key potential catalysts and top ideas for 2013 on an Analyst/Industry conference call. Relevant covered companies ABT, BAX, BCR, BSX, BDX, CFN, COV, EW, HSP, HTWR, MDT, NUVA, STJ, SYK, TFX, THOR and ZMH will be discussed on the Analyst/Industry conference call to be held January 17 at 10 am.
News For ABT;BAX;BCR;BSX;BDX;CFN;COV;EW;HSP;HTWR;MDT;NUVA;STJ;SYK;TFX;THOR;ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 >>
August 26, 2015
11:55 EDTTFXTeleflex recalls 62,882 Hudson RCI Sheridan tubes
Teleflex is recalling 62,882 Hudson RCI Sheridan Sher-I-Bronch Endobronchial Tubes manufactured from October 2013 to April 2015, according to a notice posted on the FDA's website. Teleflex Medical has received customer complaints about the endobroncial tube's double swivel connector. The connector may break or separate on the tube. If this happens, the device may leak, causing the patient to not receive enough oxygen or experience respiratory distress. This can lead to the need to re-intubate the patient, patient injury or death. The recall is Class I and was initiated on June 1.
09:20 EDTBDXFluidigm has negative read through from Becton Dickinson deal, says Leerink
Subscribe for More Information
August 25, 2015
16:09 EDTBDXBecton Dickinson unit acquires Cellular Research to develop genomics platform
Subscribe for More Information
09:26 EDTHSPHospira, Cerner expand IV-EMR integration agreement
Subscribe for More Information
09:07 EDTMDTMedtronic to acquire Twelve for $458M
In support of the company's therapy innovation strategy, Medtronic announced that it has signed a definitive agreement to acquire Twelve, a medical device company focused on the development of a transcatheter mitral valve replacement, or TMVR device. Twelve is the twelfth company spun out from the premier medical device incubator The Foundry. Medtronic has agreed to pay up to $458M for Twelve including $408M at closing and $50M on achievement of CE Marking. The cash- and debt-free transaction remains subject to customary closing conditions, and is expected to close in October 2015.
07:54 EDTSTJSt. Jude Medical management to meet with Oppenheimer
Subscribe for More Information
07:32 EDTSYKStryker margins poised to increase, says Stifel
Subscribe for More Information
07:29 EDTCFN, BDXBecton Dickinson acquisition positive, says Stifel
Subscribe for More Information
07:02 EDTNUVANuVasive exploring locations to build medical device facility
Subscribe for More Information
August 24, 2015
16:32 EDTBSXBoston Scientific announces CE Mark for MRI labeling for ICD, CRT-D systems
Boston Scientific has received CE Mark on magnetic resonance imaging conditional labeling for the current family of EL and MINI implantable cardioverter defibrillator and the X4 cardiac resynchronization therapy defibrillator systems. This revised labeling ensures that future patients and those already implanted with these systems are able to undergo MRI scans if indicated.
12:57 EDTHSPFTC requires Pfizer to sell rights to four products as condition of buying Hospira
Subscribe for More Information
09:45 EDTTHOROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:31 EDTSTJSt. Jude Medical receives CE Mark for MRI labeling for Prodigy MRI system
Subscribe for More Information
08:29 EDTEW, NUVA, THORWilliam Blair to hold a field trip
Subscribe for More Information
08:01 EDTHSPPfizer receives clearance from FTC for Hospira acquisition
Subscribe for More Information
06:39 EDTTHORThoratec downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
06:19 EDTTHORThoratec downgraded to Market Perform from Outperform at Leerink
Leerink downgraded Thoratec (THOR) to Hold from Buy ahead of the closing of its merger transaction with St. Jude Medical (STJ), which is expected to close by year-end.
August 21, 2015
09:01 EDTSYKLeerink medical devices analyst holds an analyst/industry conference call
Medical Device Analyst Newitter, along with MEDACorp Specialists Dorance Dillon and Terence Farrell, discuss the Centers for Medicare & Medicaid Services' recently proposed "Comprehensive Care For Joint Replacement Payment Model" and how this model might influence ortho pricing and hospital-vendor relationships on an Analyst/Industry conference call to be held on August 24 at 1 pm.
08:50 EDTSTJ, THORThoratec announces end of 'go shop' period in merger agreement with St. Jude
Subscribe for More Information
August 20, 2015
05:26 EDTHSPHospira announces approval of Inflectra in Australia
Subscribe for More Information
1 | 2 | 3 | 4 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use